{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-018514","form_type":"8-K","ticker":"RLAY","cik":"0001812364","company_name":"Relay Therapeutics, Inc.","filed_at":"2022-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.130853+00:00","generated_at":"2026-06-23T09:28:38.855346+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Relay Therapeutics prices $300M public offering of 11.32M shares at $26.50 per share","bullets":["Priced public offering of 11,320,755 shares at $26.50/share; gross proceeds ~$300M.","Net proceeds expected ~$284.5M after underwriting discounts and expenses.","Underwriters granted 30-day option to buy up to 1,698,113 additional shares.","Offering expected to close on September 15, 2022; Goldman Sachs, J.P. Morgan, Cowen, BofA act as managers.","All shares sold by Relay Therapeutics; shelf registration effective."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-018514","json":"https://secwatch.observer/filing/0000950170-22-018514.json","markdown":"https://secwatch.observer/filing/0000950170-22-018514.md","text":"https://secwatch.observer/filing/0000950170-22-018514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812364/000095017022018514/0000950170-22-018514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812364/000095017022018514/rlay-20220912.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:28:38.855346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}